• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于分离适合靶向治疗的钇-90的电化学锶-90/钇-90发生器的研制。

Development of an electrochemical 90 Sr-90 Y generator for separation of 90 Y suitable for targeted therapy.

作者信息

Chakravarty Rubel, Pandey Usha, Manolkar Remani B, Dash Ashutosh, Venkatesh Meera, Pillai M R Ambikalmajan

机构信息

Radiopharmaceuticals Division, Bhabha Atomic Research Centre, Mumbai-400085, India.

出版信息

Nucl Med Biol. 2008 Feb;35(2):245-53. doi: 10.1016/j.nucmedbio.2007.10.009.

DOI:10.1016/j.nucmedbio.2007.10.009
PMID:18312836
Abstract

UNLABELLED

90 Y of high specific activity and very high radionuclidic purity (>99.998%) is essential for targeted therapy. Since the current methods used for the preparation of 90 Y from 90 Sr are not adaptable for use in a central/hospital radiopharmacy, a simple 90 Sr-90 Y generator system based on electrochemical separation technique was developed.

METHODS

Two-cycle electrolysis procedure was developed for separation of 90 Y from 90 Sr in nitrate solution. The first electrolysis was performed for 90 min in 90 Sr(NO3)2 feed solution at pH 2-3 at a potential of -2.5 V with 100-200 mA current using platinum electrodes. The second electrolysis was performed for 45 min in 3 mM HNO3 at a potential of -2.5 V with 100 mA current. In this step, the cathode from the first electrolysis containing 90 Y was used as anode along with a fresh circular platinum electrode as cathode. The 90 Y deposited on the circular cathode after the second electrolysis was dissolved in acetate buffer to obtain 90 Y acetate, suitable for radiolabeling.

RESULTS

96% recovery of 90 Y could be achieved in each cycle, with an overall decay corrected yield of >90%. The recovered 90 Y had high radionuclidic purity with barely 30.2+/-15.2 kBq (817+/-411 nCi) of 90 Sr per 37 GBq (1 Ci) of 90 Y (0.817+/-0.411 ppm). Consistent and repeated separation could be demonstrated using up to 1.85 GBq (50 mCi) of 90 Sr. The generator was named "Kamadhenu," the eternally milk-yielding Indian mythological cow.

CONCLUSIONS

A technique suitable for adaptation at central radiopharmacies for obtaining therapeutic quantities of pure 90 Y has been developed.

摘要

未标记

高比活度且放射性核素纯度极高(>99.998%)的钇-90对于靶向治疗至关重要。由于目前从锶-90制备钇-90所使用的方法不适用于中心/医院放射性药房,因此开发了一种基于电化学分离技术的简易锶-90 - 钇-90发生器系统。

方法

开发了一种两循环电解程序,用于在硝酸盐溶液中从锶-90分离钇-90。第一次电解在pH值为2 - 3的锶-90(硝酸锶)进料溶液中进行90分钟,使用铂电极,电位为 - 2.5 V,电流为100 - 200 mA。第二次电解在3 mM硝酸中进行45分钟,电位为 - 2.5 V,电流为100 mA。在这一步骤中,将第一次电解含有钇-90的阴极用作阳极,同时使用一个新的圆形铂电极作为阴极。第二次电解后沉积在圆形阴极上的钇-90溶解在醋酸盐缓冲液中,以获得适用于放射性标记的醋酸钇-90。

结果

每个循环中钇-90的回收率>96%,经衰变校正后的总产率>90%。回收的钇-90具有高放射性核素纯度,每37 GBq(1 Ci)钇-90中锶-90的含量仅为30.2±15.2 kBq(817±411 nCi)(0.817±0.411 ppm)。使用高达1.85 GBq(50 mCi)的锶-90可以证明能够进行一致且重复的分离。该发生器被命名为“Kamadhenu”,即印度神话中能永远产奶的母牛。

结论

已开发出一种适用于中心放射性药房的技术,可用于获得治疗量的纯钇-90。

相似文献

1
Development of an electrochemical 90 Sr-90 Y generator for separation of 90 Y suitable for targeted therapy.用于分离适合靶向治疗的钇-90的电化学锶-90/钇-90发生器的研制。
Nucl Med Biol. 2008 Feb;35(2):245-53. doi: 10.1016/j.nucmedbio.2007.10.009.
2
Rapid determination of (90)Sr impurities in freshly "generator eluted"(90)Y for radiopharmaceutical preparation.
Appl Radiat Isot. 2009 Oct;67(10):1874-7. doi: 10.1016/j.apradiso.2009.06.005. Epub 2009 Jun 21.
3
High efficiency production and purification of 86Y based on electrochemical separation.基于电化学分离的86Y高效生产与纯化
Appl Radiat Isot. 2009 Apr;67(4):523-9. doi: 10.1016/j.apradiso.2008.12.008. Epub 2008 Dec 24.
4
Production of large quantities of 90Y by ion-exchange chromatography using an organic resin and a chelating agent.采用有机树脂和螯合剂通过离子交换色谱法生产大量 90Y。
Nucl Med Biol. 2010 Nov;37(8):935-42. doi: 10.1016/j.nucmedbio.2010.03.017. Epub 2010 Aug 16.
5
Preparation of high specific activity (86)Y using a small biomedical cyclotron.使用小型生物医学回旋加速器制备高比活度(86)钇。
Nucl Med Biol. 2005 Nov;32(8):891-7. doi: 10.1016/j.nucmedbio.2005.06.007.
6
Facile radiochemical separation of clinical-grade Y from Sr by selective precipitation for targeted radionuclide therapy.通过选择性沉淀从 Sr 中简便地放射化学分离临床级 Y,用于靶向放射性核素治疗。
Nucl Med Biol. 2019 Jan-Feb;68-69:58-65. doi: 10.1016/j.nucmedbio.2019.01.002. Epub 2019 Jan 19.
7
Determination of 90Sr traces in medical 90Y after separation on DGA column.用 DGA 柱分离后测定医用 90Y 中的 90Sr 痕量。
Talanta. 2013 Sep 30;114:1-4. doi: 10.1016/j.talanta.2013.03.081. Epub 2013 Apr 9.
8
Availability of yttrium-90 from strontium-90: a nuclear medicine perspective.从核医学的角度看钇-90 源自锶-90 的可得性。
Cancer Biother Radiopharm. 2012 Dec;27(10):621-41. doi: 10.1089/cbr.2012.1285. Epub 2012 Sep 25.
9
Excitation functions of (alpha,xn) reactions on (nat)Rb and (nat)Sr from threshold up to 26 MeV: possibility of production of (87)Y, (88)Y and (89)Zr.从阈能到26兆电子伏,天然铷(natRb)和天然锶(natSr)上(α,xn)反应的激发函数:产生钇-87(87Y)、钇-88(88Y)和锆-89(89Zr)的可能性
Appl Radiat Isot. 2007 May;65(5):561-8. doi: 10.1016/j.apradiso.2006.12.007. Epub 2007 Jan 30.
10
Behavior of aluminum electrodes in electrocoagulation process.铝电极在电凝聚过程中的行为。
J Hazard Mater. 2008 Jan 15;150(1):124-35. doi: 10.1016/j.jhazmat.2007.04.090. Epub 2007 Apr 24.

引用本文的文献

1
In situ radiochemical doping of functionalized inorganic nanoplatforms for theranostic applications: a paradigm shift in nanooncology.用于诊疗应用的功能化无机纳米平台的原位放射化学掺杂:纳米肿瘤学的范式转变
J Nanobiotechnology. 2025 Jun 2;23(1):407. doi: 10.1186/s12951-025-03472-1.
2
Sorption Characteristics and Chromatographic Separation of Y from Sr from Aqueous Media by Chelex-100 (Anion Ion Exchange) Packed Column.通过Chelex-100(阴离子交换)填充柱从水介质中吸附Y和Sr的特性及色谱分离
Int J Anal Chem. 2024 May 13;2024:6232381. doi: 10.1155/2024/6232381. eCollection 2024.
3
Production of radiometals in liquid targets.
液态靶中放射性金属的生产。
EJNMMI Radiopharm Chem. 2020 Jan 10;5(1):2. doi: 10.1186/s41181-019-0088-x.
4
Preliminary evaluation of indigenous Y-labelled microspheres for therapy of hepatocellular carcinoma.用于肝细胞癌治疗的国产钇标记微球的初步评估。
Indian J Med Res. 2016 May;143(Supplement):S74-S81. doi: 10.4103/0971-5916.191786.
5
Preparation & in vitro evaluation of ⁹⁰Y-DOTA-rituximab.90Y-DOTA-利妥昔单抗的制备及体外评价
Indian J Med Res. 2016 Jan;143(1):57-65. doi: 10.4103/0971-5916.178593.
6
Coordinating radiometals of copper, gallium, indium, yttrium, and zirconium for PET and SPECT imaging of disease.用于疾病正电子发射断层扫描(PET)和单光子发射计算机断层扫描(SPECT)成像的铜、镓、铟、钇和锆等配位放射性金属。
Chem Rev. 2010 May 12;110(5):2858-902. doi: 10.1021/cr900325h.